PubRank

Fatima Ferreira

Author PubWeight™ 66.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002 1.66
2 Antigen aggregation decides the fate of the allergic immune response. J Immunol 2009 1.64
3 From allergen genes to allergy vaccines. Annu Rev Immunol 2010 1.46
4 Nomenclature and structural biology of allergens. J Allergy Clin Immunol 2006 1.45
5 Distinct roles of secreted HtrA proteases from gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherin. J Biol Chem 2012 1.31
6 Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization. J Immunol 2007 1.25
7 The spectrum of allergens in ragweed and mugwort pollen. Int Arch Allergy Immunol 2005 1.10
8 Plant-based heterologous expression of Mal d 2, a thaumatin-like protein and allergen of apple (Malus domestica), and its characterization as an antifungal protein. J Mol Biol 2003 1.09
9 Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 2002 1.09
10 Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals. Proc Natl Acad Sci U S A 2013 1.09
11 Reshaping the Bet v 1 fold modulates T(H) polarization. J Allergy Clin Immunol 2011 1.05
12 Mutational analysis of amino acid positions crucial for IgE-binding epitopes of the major apple (Malus domestica) allergen, Mal d 1. Int Arch Allergy Immunol 2005 1.02
13 The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines. J Allergy Clin Immunol 2008 1.01
14 Naturally processed T cell-activating peptides of the major birch pollen allergen. J Allergy Clin Immunol 2010 1.00
15 Response to Detection and analysis of unusual features in the structural model and structure-factor data of a birch pollen allergen. Acta Crystallogr Sect F Struct Biol Cryst Commun 2012 0.96
16 Nitration of the pollen allergen bet v 1.0101 enhances the presentation of bet v 1-derived peptides by HLA-DR on human dendritic cells. PLoS One 2012 0.95
17 Molecular and immunological characterization of ragweed (Ambrosia artemisiifolia L.) pollen after exposure of the plants to elevated ozone over a whole growing season. PLoS One 2013 0.95
18 The role of lipid transfer proteins in allergic diseases. Curr Allergy Asthma Rep 2010 0.93
19 Human placental development is impaired by abnormal human chorionic gonadotropin signaling in trisomy 21 pregnancies. Endocrinology 2007 0.93
20 Biology of weed pollen allergens. Curr Allergy Asthma Rep 2004 0.92
21 Humoral and cellular cross-reactivity between Amb a 1, the major ragweed pollen allergen, and its mugwort homolog Art v 6. J Immunol 2011 0.92
22 Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites. PLoS One 2010 0.91
23 Ozone affects pollen viability and NAD(P)H oxidase release from Ambrosia artemisiifolia pollen. Environ Pollut 2011 0.91
24 The T-cell response to Amb a 1 is characterized by 3 dominant epitopes and multiple MHC restriction elements. J Allergy Clin Immunol 2010 0.89
25 Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy. J Allergy Clin Immunol 2006 0.89
26 A new allergen from ragweed (Ambrosia artemisiifolia) with homology to art v 1 from mugwort. J Biol Chem 2010 0.89
27 Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening. J Allergy Clin Immunol 2010 0.88
28 Biochemical characterization and modulation of LH/CG-receptor during human trophoblast differentiation. J Cell Physiol 2007 0.88
29 Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy. PLoS One 2012 0.87
30 Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001. Immunobiology 2009 0.87
31 Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. J Allergy Clin Immunol 2005 0.86
32 The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope. J Immunol 2002 0.86
33 The influence of recombinant production on the immunologic behavior of birch pollen isoallergens. PLoS One 2009 0.86
34 Isoform identification and characterization of Art v 3, the lipid-transfer protein of mugwort pollen. Mol Immunol 2009 0.86
35 Mapping the interactions between a major pollen allergen and human IgE antibodies. Structure 2010 0.86
36 Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergy. J Allergy Clin Immunol 2003 0.85
37 Proteomic and immunochemical characterization of glutathione transferase as a new allergen of the nematode Ascaris lumbricoides. PLoS One 2013 0.85
38 Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens. J Allergy Clin Immunol 2009 0.85
39 Recombinant allergens for pollen immunotherapy. Immunotherapy 2013 0.85
40 Cloning of oleosin, a putative new hazelnut allergen, using a hazelnut cDNA library. Mol Nutr Food Res 2006 0.84
41 Allergen standardization: CREATE principles applied to other purified allergens. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess 2009 0.84
42 Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen. Eur J Immunol 2003 0.84
43 Is genetic vaccination against allergy possible? Int Arch Allergy Immunol 2006 0.84
44 Stabilization of the dimeric birch pollen allergen Bet v 1 impacts its immunological properties. J Biol Chem 2013 0.84
45 Calcium-binding proteins and their role in allergic diseases. Immunol Allergy Clin North Am 2007 0.83
46 Expression of the major mugwort pollen allergen Art v 1 in tobacco plants and cell cultures: problems and perspectives for allergen production in plants. Plant Cell Rep 2011 0.83
47 Prophylactic mRNA vaccination against allergy. Curr Opin Allergy Clin Immunol 2010 0.83
48 The alpha and beta subchain of Amb a 1, the major ragweed-pollen allergen show divergent reactivity at the IgE and T-cell level. Mol Immunol 2009 0.82
49 Role of the polypeptide backbone and post-translational modifications in cross-reactivity of Art v 1, the major mugwort pollen allergen. Biol Chem 2009 0.82
50 Development of recombinant allergens for diagnosis and therapy. Front Biosci (Elite Ed) 2009 0.82
51 Sensitization prevalence, antibody cross-reactivity and immunogenic peptide profile of Api g 2, the non-specific lipid transfer protein 1 of celery. PLoS One 2011 0.82
52 Phage display based cloning of proteins interacting with the cytoplasmic tail of membrane immunoglobulins. Dev Immunol 2002 0.81
53 Over-expression and production of plant allergens by molecular farming strategies. Methods 2004 0.81
54 Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen. J Immunol 2008 0.81
55 Peach allergy in China: a dominant role for mugwort pollen lipid transfer protein as a primary sensitizer. J Allergy Clin Immunol 2012 0.80
56 Production of recombinant allergens in plants. Phytochem Rev 2008 0.80
57 Molecular characterization of Api g 2, a novel allergenic member of the lipid-transfer protein 1 family from celery stalks. Mol Nutr Food Res 2010 0.80
58 Molecular and immunological characterization of profilin from mugwort pollen. Biol Chem 2002 0.80
59 Specific immunotherapy in pollen allergy. Curr Opin Mol Ther 2007 0.80
60 Molecular metamorphosis in polcalcin allergens by EF-hand rearrangements and domain swapping. FEBS J 2010 0.79
61 Allergy multivaccines created by DNA shuffling of tree pollen allergens. J Allergy Clin Immunol 2007 0.79
62 Is aboriginal food less allergenic? Comparing IgE-reactivity of eggs from modern and ancient chicken breeds in a cohort of allergic children. PLoS One 2011 0.79
63 Allergenic relevance of nonspecific lipid transfer proteins 2: Identification and characterization of Api g 6 from celery tuber as representative of a novel IgE-binding protein family. Mol Nutr Food Res 2013 0.79
64 Expression in Escherichia coli and purification of human recombinant connexin-43, a four-pass transmembrane protein. Protein Expr Purif 2011 0.78
65 A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin. J Immunol 2007 0.78
66 BSP090--the follow-up to CREATE. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess 2009 0.78
67 Targeting the cysteine-stabilized fold of Art v 1 for immunotherapy of Artemisia pollen allergy. Mol Immunol 2010 0.77
68 The fold variant BM4 is beneficial in a therapeutic Bet v 1 mouse model. Biomed Res Int 2013 0.76
69 Allergic reactions to manioc (Manihot esculenta Crantz): identification of novel allergens with potential involvement in latex-fruit syndrome. J Allergy Clin Immunol 2011 0.76
70 Specific allergen concentration of WHO and FDA reference preparations measured using a multiple allergen standard. J Allergy Clin Immunol 2012 0.76
71 Sequence-specific 1H, 15N and 13C resonance assignments of Art v 1: a proline-rich allergen of Artemisia vulgaris pollen. Biomol NMR Assign 2009 0.75
72 Can we predict or avoid the allergenic potential of genetically modified organisms? Int Arch Allergy Immunol 2005 0.75
73 Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity. World Allergy Organ J 2011 0.75
74 TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: no evidence for the synthesis of nonanaphylactic IgG1. J Allergy Clin Immunol 2003 0.75
75 Experimental forms of allergen immunotherapy with modified allergens and adjuvants. Clin Allergy Immunol 2008 0.75
76 Allergens of Blomia tropicalis: An Overview of Recombinant Molecules. Int Arch Allergy Immunol 2017 0.75
77 Strategies for the development of safe and effective DNA vaccines for allergy treatment. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2003 0.75
78 Characterization of allergoids. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess 2009 0.75
79 Modifying allergens and using adjuvants for specific immunotherapy. Clin Allergy Immunol 2004 0.75